🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.

RecruitingNAAges 18 Years - anyAllCentral Hospital, Nancy, France
NCT06257134 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In France, end-stage renal disease (ESRD) affects almost 170 people per million inhabitants every year, and 92,500 people are treated by dialysis or kidney transplantation (0.14% of the French population). The treatment of chronic renal failure is extremely costly: 4 billion euros in 2021, i.e. 2% of health insurance expenditure, and an annual cost of 42,000 euros per patient. The health-related quality of life (HRQoL) of dialysis patients is low, with reports of patients at 40%-60% of full health. In France, there has been a significant decrease in physical (-15.4 points) and mental (-6.9 points) component scores compared with the general population. Dialysis patients often present severe or overwhelming symptoms, which contribute to this poor HRQoL. However, in nephrology, studies have focused on survival and laboratory biomarkers, and very few interventions have been aimed at improv

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Symptom collection phase The inclusion criteria for patients are as follows: * Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data. * Adults aged 18 and over * Patients with end-stage renal disease treated by dialysis in participating dialysis units * Patients able to answer questionnaires Process evaluation phase The inclusion criteria for healthcare professionals are as follows: * Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data. * Patients with end-stage renal disease treated by dialysis in participating dialysis units. * Doctors and nurses working in the dialysis unit taking part in the study. Exclusion Criteria: The non-inclusion criteria for patients are as follows: * Minors * Patients under legal protection, guardianship or curatorship * Patient not communicating or unable to give consent * Patient not being treated in a dialysis unit participating in the study * Patients being treated temporarily in a participating dialysis unit (respite care, vacationers, etc.) * Patient with cognitive disorders * Patient unable or unwilling to answer questionnaires The non-inclusion criteria for healthcare professionals are as follows: * Non-voluntary healthcare professional * Healthcare professional not working in the participating facility
💊

What it tests

  • No systematic monitoring of symptoms
  • Systematic monitoring of symptoms
📍

Where

3 sites
Maison du Rein AURAD Aquitaine
Gradignan, France
ALTIR
Vandœuvre-lès-Nancy, France
CHRU Nancy
Vandœuvre-lès-Nancy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy